Jefferies International Ltd.

Jefferies International Ltd. is slightly increasing its 3Q10 EPS estimates for most of the dry bulk shipping names under coverage to reflect slightly higher than expected Panamax and Handymax spot charter rates during the quarter. “We are also modestly reducing our 4Q10 and 2011 EPS estimates for...

Jefferies International Ltd. is out with a research report this morning, where it reiterates its Hold rating on Eli Lilly (NYSE: LLY); it has a $35.00 price target on the stock. The Jefferies analysts noted the FDA Anesthetic and Life Support Drugs AdCom, which was scheduled to discuss the...

Bristol Myers Squibb Company (NYSE: BMY) reported 2Q results allude to potential for revenues in the future, according to Jefferies International, who believes that the shares are priced for perfect execution of the late-stage pipeline. Jefferies has raised the price target for BMY to $28.80 from $...

Earlier today, Jefferies International Ltd. issued a note on Bayer AG. They said that "faltering CropScience and MaterialScience uncertainties [will] drag on valuation." According to the analysts, "Near-term EBITDA growth will primarily driven by the recovery in MaterialScience, with more limited...

Analysts at Jefferies International Ltd. published a research note on Bristol-Myers Squibb (NYSE: BMY) earlier today, raising its estimates and price target. "With a high PE multiple relative to its peers, we believe that investors have priced the shares for perfect execution of the late-stage...